# Alignment Healthcare, Inc.: filings

ALHC · Nasdaq · CIK 1832466 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/alhc.md) · [Financials](/companies/alhc/financials.md) · [Filings](/companies/alhc/filings.md) · [Insiders](/companies/alhc/insiders.md)

## Reports and events: 88 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 412, 144 189, 8-K 54, 3 34, 10-Q 18, SCHEDULE 13G/A 15, 4/A 7, CORRESP 7, SC 13G/A 7, DEFA14A 6, SC 13G 6, SCHEDULE 13G 6, 10-K 5, DEF 14A 5, ARS 4, UPLOAD 4, 3/A 3, 424B7 3, 424B4 2, 8-K/A 2, DRS 2, DRS/A 2, DRSLTR 2, EFFECT 2, S-1 2, S-1/A 2, S-3ASR 2, S-8 2, 144/A 1, 8-A12B 1, CERT 1, PRE 14A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 16:15 ET | [10-Q](/filings/0001628280-26-068247.md) | Quarterly report, period 2026-09-30 | 0001628280-26-068247 |
| 2026-10-29 | 16:01 ET | [8-K](/filings/0001171843-26-006971.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-006971 |
| 2026-10-08 | 17:13 ET | [8-K](/filings/0001628280-26-065470.md) | 7.01 Regulation FD disclosure | 0001628280-26-065470 |
| 2026-07-30 | 16:14 ET | [10-Q](/filings/0001628280-26-051060.md) | Quarterly report, period 2026-06-30 | 0001628280-26-051060 |
| 2026-07-30 | 16:01 ET | [8-K](/filings/0001171843-26-005078.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005078 |
| 2026-06-09 | 16:31 ET | [8-K](/filings/0001628280-26-041926.md) | 5.07 Shareholder vote results | 0001628280-26-041926 |
| 2026-05-12 | 16:33 ET | [8-K](/filings/0001628280-26-034147.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure | 0001628280-26-034147 |
| 2026-04-30 | 16:14 ET | [10-Q](/filings/0001628280-26-028901.md) | Quarterly report, period 2026-03-31 | 0001628280-26-028901 |
| 2026-04-30 | 16:01 ET | [8-K](/filings/0001171843-26-002895.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-002895 |
| 2026-04-24 | 10:52 ET | [DEF 14A](/filings/0001628280-26-027058.md) | Proxy statement, period 2026-06-04 | 0001628280-26-027058 |
| 2026-03-04 | 16:08 ET | [8-K](/filings/0001193125-26-091486.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-091486 |
| 2026-02-27 | 21:18 ET | [10-K](/filings/0001628280-26-012545.md) | Annual report, period 2025-12-31 | 0001628280-26-012545 |
| 2026-02-26 | 16:01 ET | [8-K](/filings/0001171843-26-001139.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-001139 |
| 2026-01-12 | 09:10 ET | [8-K](/filings/0001628280-26-001783.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-001783 |
| 2025-10-30 | 16:11 ET | [10-Q](/filings/0001628280-25-047538.md) | Quarterly report, period 2025-09-30 | 0001628280-25-047538 |
| 2025-10-30 | 16:01 ET | [8-K](/filings/0001171843-25-006831.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-006831 |
| 2025-09-09 | 17:03 ET | [8-K](/filings/0001832466-25-000006.md) | 7.01 Regulation FD disclosure | 0001832466-25-000006 |
| 2025-07-30 | 16:11 ET | [10-Q](/filings/0001628280-25-036713.md) | Quarterly report, period 2025-06-30 | 0001628280-25-036713 |
| 2025-07-30 | 16:01 ET | [8-K](/filings/0001171843-25-004825.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-004825 |
| 2025-06-11 | 17:06 ET | [8-K](/filings/0001628280-25-030795.md) | 5.07 Shareholder vote results | 0001628280-25-030795 |
| 2025-05-01 | 16:30 ET | [10-Q](/filings/0001628280-25-021571.md) | Quarterly report, period 2025-03-31 | 0001628280-25-021571 |
| 2025-05-01 | 16:01 ET | [8-K](/filings/0001171843-25-002689.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-002689 |
| 2025-04-25 | 16:17 ET | [DEF 14A](/filings/0001628280-25-019952.md) | Proxy statement, period 2025-06-05 | 0001628280-25-019952 |
| 2025-04-15 | 16:38 ET | [8-K](/filings/0001628280-25-017872.md) | 5.02 Departure or appointment of officers or directors | 0001628280-25-017872 |
| 2025-04-11 | 16:45 ET | [8-K](/filings/0001628280-25-017553.md) | 8.01 Other events | 0001628280-25-017553 |
| 2025-02-27 | 16:50 ET | [10-K](/filings/0001628280-25-008730.md) | Annual report, period 2024-12-31 | 0001628280-25-008730 |
| 2025-02-27 | 16:01 ET | [8-K](/filings/0001171843-25-001127.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001127 |
| 2025-01-13 | 08:44 ET | [8-K](/filings/0001628280-25-001253.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-001253 |
| 2024-11-25 | 16:44 ET | [8-K](/filings/0001628280-24-049159.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001628280-24-049159 |
| 2024-11-15 | 06:50 ET | [8-K](/filings/0001628280-24-048032.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-048032 |
| 2024-10-29 | 16:04 ET | [10-Q](/filings/0001628280-24-044092.md) | Quarterly report, period 2024-09-30 | 0001628280-24-044092 |
| 2024-10-29 | 16:01 ET | [8-K](/filings/0001171843-24-005854.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-005854 |
| 2024-08-16 | 16:43 ET | [8-K](/filings/0001628280-24-037577.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-037577 |
| 2024-08-01 | 16:04 ET | [10-Q](/filings/0001628280-24-034114.md) | Quarterly report, period 2024-06-30 | 0001628280-24-034114 |
| 2024-08-01 | 16:01 ET | [8-K](/filings/0001171843-24-004355.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004355 |
| 2024-06-14 | 17:18 ET | [8-K](/filings/0001628280-24-028334.md) | 2.03 New direct financial obligation | 0001628280-24-028334 |
| 2024-06-13 | 17:42 ET | [8-K](/filings/0001628280-24-027889.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-24-027889 |
| 2024-06-06 | 16:59 ET | [8-K](/filings/0001628280-24-027112.md) | 8.01 Other events | 0001628280-24-027112 |
| 2024-05-02 | 16:06 ET | [10-Q](/filings/0001628280-24-019994.md) | Quarterly report, period 2024-03-31 | 0001628280-24-019994 |
| 2024-05-02 | 16:01 ET | [8-K](/filings/0001171843-24-002487.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-002487 |
| 2024-04-26 | 09:02 ET | [DEF 14A](/filings/0001193125-24-116055.md) | Proxy statement, period 2024-06-07 | 0001193125-24-116055 |
| 2024-02-27 | 16:14 ET | [10-K](/filings/0000950170-24-021154.md) | Annual report, period 2023-12-31 | 0000950170-24-021154 |
| 2024-02-27 | 16:01 ET | [8-K](/filings/0001171843-24-001014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-001014 |
| 2024-01-08 | 08:01 ET | [8-K](/filings/0000950170-24-002706.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-002706 |
| 2023-12-29 | 17:07 ET | [8-K](/filings/0000950170-23-073907.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-073907 |
| 2023-11-02 | 16:11 ET | [10-Q](/filings/0000950170-23-058207.md) | Quarterly report, period 2023-09-30 | 0000950170-23-058207 |
| 2023-11-02 | 16:02 ET | [8-K](/filings/0001171843-23-006669.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-23-006669 |
| 2023-09-15 | 17:00 ET | [8-K](/filings/0000950170-23-048416.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-048416 |
| 2023-09-06 | 16:46 ET | [8-K](/filings/0000950170-23-046764.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-046764 |
| 2023-08-15 | 16:37 ET | [8-K](/filings/0000950170-23-042834.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-042834 |

Page 1 of 2. [Older](/companies/alhc/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 18:01 ET. No prices; not investment advice.